(Q46275214)

21 December 2017

title

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months (English)

1 reference

21 December 2017

autosomal dominant polycystic kidney disease

main subject

0 references

autosomal dominant polycystic kidney

1 reference

6

1 reference

21 December 2017

Fabienne Krauer

object named as

Fabienne Krauer

3

0 references

author name string

Andreas D Kistler

1

1 reference

21 December 2017

Diane Poster

2

1 reference

21 December 2017

Dominik Weishaupt

4

1 reference

21 December 2017

Shagun Raina

5

1 reference

21 December 2017

Isabelle Binet

7

1 reference

21 December 2017

Katharina Spanaus

8

1 reference

21 December 2017

Rudolf P Wüthrich

9

1 reference

21 December 2017

Andreas L Serra

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

29 October 2008

1 reference

21 December 2017

published in

Kidney International

1 reference

21 December 2017

volume

75

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

235-241

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.558

exact match

0 references

cites work

Polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Rate of functional deterioration in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Potential pharmacological interventions in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Volume progression in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Measuring error and sampling variation in stereology: comparison of the efficiency of various methods for planar image analysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Determinants of renal volume in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

A concordance correlation coefficient to evaluate reproducibility

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.558

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2008.558

1 reference

7 January 2021

Identifiers

DOI

10.1038/KI.2008.558

1 reference

21 December 2017

Dimensions Publication ID

0 references

1 reference

21 December 2017